Neuronetics, Inc. (STIM)Healthcare | Medical Devices | Malvern, United States | NasdaqGM
1.79 USD
+0.03
(1.705%)
⇧
(July 13, 2026, 4 p.m.
EDT)
After hours: 1.77 -0.02 (-0.020%) ⇩ (July 13, 2026, 7:39 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 5:32 a.m. EDT
The investment case for Neuronetics is currently fractured by a severe disconnect between its operational reality and its market valuation. Fundamentally, the company is in distress: it is burning cash, generating negative operating margins, and carries a debt load nearly six times its equity. While revenue is growing at a modest 7.8%, this growth is insufficient to offset the capital destruction or justify the current price-to-book ratio of over 9x. The multi-year price trajectory confirms the market's skepticism, with the stock down 86% over the last seven years despite a recent recovery in the latest annual report. The short-term outlook remains murky. While the stock has rallied recently, bouncing off multi-year lows, the statistical forecast models offer no directional clarity, and the options market is screaming caution. The sheer volume of put buying at distant strikes suggests that sophisticated traders see a high probability of a sharp decline ahead, likely triggered by the upcoming earnings date or activist pressure failing to materialize into results. Without a clear path to profitability or a massive catalyst to re-rate the balance sheet, the risk-reward profile is skewed heavily against the buyer. This is a speculative vehicle for high-risk tolerance investors, not a core holding. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.132351 |
| MSTL | 0.132572 |
| MSTL_126 | 0.133341 |
| AutoETS | 0.134357 |
| AutoARIMA | 0.134412 |
Forecast horizon: 60 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 35% |
| H-stat | 0.33 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.102 |
| Excess Kurtosis | -0.49 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 500.516 |
| Revenue per Share | 2.231 |
| Market Cap | 124,562,232 |
| Forward P/E | -5.32 |
| Beta | 1.06 |
| Profit Margins | -24.48% |
| Website | https://neurostar.com/neuronetics |
As of July 11, 2026, 5:32 a.m. EDT: Speculators are positioning aggressively for a downside event in August, evidenced by massive open interest in deep out-of-the-money puts ($5 strike) compared to negligible call activity. Conversely, near-term expirations show heavy call volume at lower strikes ($1.50), suggesting a 'pin the price' strategy or a belief that the stock will bounce from current lows rather than crash immediately. The extreme disparity in implied volatility between calls and puts indicates a market pricing in significant downside risk.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.54404145 |
| Address1 | 3,222 Phoenixville Pike |
| All Time High | 39.39 |
| All Time Low | 0.52 |
| Ask | 2.18 |
| Ask Size | 2 |
| Audit Risk | 6 |
| Average Daily Volume10 Day | 1,623,730 |
| Average Daily Volume3 Month | 2,037,272 |
| Average Volume | 2,037,272 |
| Average Volume10Days | 1,623,730 |
| Beta | 1.061 |
| Bid | 1.32 |
| Bid Size | 2 |
| Board Risk | 4 |
| Book Value | 0.191 |
| City | Malvern |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 9 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.79 |
| Current Ratio | 1.668 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 1.85 |
| Day Low | 1.705 |
| Debt To Equity | 500.516 |
| Display Name | Neuronetics |
| Earnings Call Timestamp End | 1,777,984,200 |
| Earnings Call Timestamp Start | 1,777,984,200 |
| Earnings Timestamp | 1,777,984,200 |
| Earnings Timestamp End | 1,785,846,600 |
| Earnings Timestamp Start | 1,785,846,600 |
| Ebitda | -25,778,000 |
| Ebitda Margins | -0.17 |
| Enterprise To Ebitda | -7.779 |
| Enterprise To Revenue | 1.322 |
| Enterprise Value | 200,531,232 |
| Eps Current Year | -0.46333 |
| Eps Forward | -0.33667 |
| Eps Trailing Twelve Months | -0.55 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 610 640 4206 |
| Fifty Day Average | 1.4408 |
| Fifty Day Average Change | 0.3492 |
| Fifty Day Average Change Percent | 0.24236538 |
| Fifty Two Week Change Percent | -54.404144 |
| Fifty Two Week High | 4.85 |
| Fifty Two Week High Change | -3.06 |
| Fifty Two Week High Change Percent | -0.63092786 |
| Fifty Two Week Low | 0.8 |
| Fifty Two Week Low Change | 0.98999995 |
| Fifty Two Week Low Change Percent | 1.2375 |
| Fifty Two Week Range | 0.8 - 4.85 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,530,192,600,000 |
| Float Shares | 28,375,138 |
| Forward Eps | -0.33667 |
| Forward P E | -5.3167787 |
| Free Cashflow | -4,582,000 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 658 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.48223 |
| Gross Profits | 73,124,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.32396 |
| Held Percent Institutions | 0.59789 |
| Implied Shares Outstanding | 69,587,840 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania. |
| Long Name | Neuronetics, Inc. |
| Market | us_market |
| Market Cap | 124,562,232 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_3177427 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -37,113,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 122,474,598 |
| Number Of Analyst Opinions | 3 |
| Open | 1.73 |
| Operating Cashflow | -12,802,000 |
| Operating Margins | -0.26107 |
| Overall Risk | 7 |
| Payout Ratio | 0.0 |
| Phone | 877 600 7555 |
| Post Market Change | -0.01999998 |
| Post Market Change Percent | -1.1173174 |
| Post Market Price | 1.77 |
| Post Market Time | 1,783,985,993 |
| Previous Close | 1.76 |
| Price Eps Current Year | -3.863337 |
| Price Hint | 4 |
| Price To Book | 9.371728 |
| Price To Sales Trailing12 Months | 0.82145554 |
| Profit Margins | -0.24475001 |
| Quick Ratio | 1.035 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.03 |
| Regular Market Change Percent | 1.70454 |
| Regular Market Day High | 1.85 |
| Regular Market Day Low | 1.705 |
| Regular Market Day Range | 1.705 - 1.85 |
| Regular Market Open | 1.73 |
| Regular Market Previous Close | 1.76 |
| Regular Market Price | 1.79 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 1,603,250 |
| Return On Assets | -0.13563 |
| Return On Equity | -1.31562 |
| Revenue Growth | 0.078 |
| Revenue Per Share | 2.231 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 7 |
| Shares Outstanding | 69,587,840 |
| Shares Percent Shares Out | 0.1104 |
| Shares Short | 7,681,882 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 9,878,404 |
| Short Name | Neuronetics, Inc. |
| Short Percent Of Float | 0.2236 |
| Short Ratio | 5.23 |
| Source Interval | 15 |
| State | PA |
| Symbol | STIM |
| Target High Price | 7.0 |
| Target Low Price | 3.0 |
| Target Mean Price | 4.33333 |
| Target Median Price | 3.0 |
| Total Cash | 13,214,000 |
| Total Cash Per Share | 0.19 |
| Total Debt | 85,388,000 |
| Total Revenue | 151,636,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.55 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.739575 |
| Two Hundred Day Average Change | 0.050424933 |
| Two Hundred Day Average Change Percent | 0.028986927 |
| Type Disp | Equity |
| Volume | 1,603,250 |
| Website | https://neurostar.com/neuronetics |
| Zip | 19,355 |